OSTCP3

Across TCGA pan-cancer cohorts, OSTCP3 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated OSTCP3 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher OSTCP3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OSTCP3 expression acts as an unfavorable survival marker, although some lineages such as PRAD and KIRC show a favorable association.

LUAD, STAD, and ACC are the cancer types where OSTCP3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.692	0.855	.003	50	view →
STAD	DFS	Quartile	II,III,IV	0.477	0.849	<.001	40	view →
ACC	OS	Tertile	All	0.407	0.723	.006	37	view →
UCS	DFS	Median	All	0.124	0.472	<.001	28	view →
KICH	DFS	Tertile	All	0.644	0.914	.009	21	view →
CHOL	DFS	Median	All	0.099	0.631	.001	21	view →
PRAD	DFS	Tertile	All	0.929	0.699	<.001	18	view →
KIRP	DFS	Tertile	All	0.401	0.770	<.001	15	view →
COAD	OS	Median	II,III,IV	0.789	0.898	.009	9	view →
DLBC	DFS	Median	II,III,IV	0.554	0.951	.021	9	view →
KIRC	DFS	Quartile	All	0.749	0.574	.020	8	view →
BLCA	DFS	Median	III,IV	0.360	0.518	.003	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

OSTCP3–LUAD (OS)

Open the LUAD breakdown →